论文部分内容阅读
目的:探讨对合并呼吸衰竭的血行播散型肺结核患者进行综合治疗的临床效果。方法:对2014年2月~2015年2月期间我院收治的60例合并呼吸衰竭的血行播散型肺结核患者的临床资料进行回顾性研究。我们将这60例患者随机分为观察组和对照组,每组各有30例患者。这些患者入院后,我院对对照组患者进行常规治疗,对观察组患者进行综合治疗。治疗结束后,比较两组患者的治疗效果。结果:治疗结束后,观察组患者治疗的有效率明显高于对照组患者,二者相比差异具有显著性(P<0.05)。两组患者血液的p H值及HCO3-的水平相比差异均不具有显著性(P>0.05)。观察组患者血液Pa O2及Pa CO2的水平均明显高于对照组患者,二者相比差异具有显著性(P<0.05)。结论:对合并呼吸衰竭的血行播散型肺结核患者进行综合治疗的效果显著。此治疗方法值得在临床上推广应用。
Objective: To investigate the clinical effect of combined treatment of hematogenous disseminated pulmonary tuberculosis patients with respiratory failure. Methods: The clinical data of 60 cases of hematogenous disseminated pulmonary tuberculosis with respiratory failure admitted in our hospital from February 2014 to February 2015 were retrospectively studied. We randomly divided the 60 patients into observation and control groups, each with 30 patients in each group. After these patients were admitted to hospital, our hospital routinely treated patients in the control group and comprehensively treated the patients in the observation group. After treatment, the treatment effect of two groups of patients was compared. Results: After treatment, the effective rate of treatment in observation group was significantly higher than that in control group, the difference was significant (P <0.05). There was no significant difference in p H value and HCO3- level between the two groups (P> 0.05). PaO2 and PaCO2 in the observation group were significantly higher than those in the control group, the difference was significant (P <0.05). Conclusion: Comprehensive treatment of hematogenous disseminated pulmonary tuberculosis patients with respiratory failure is significant. This treatment is worth promoting in clinical application.